Dr. Stephen Levine Reflects on 40 Years in Gender Medicine. - Original Rebels Series (#21
A psychiatrist who co-founded one of America's first gender clinics in 1974 and later chaired a WPATH standards committee reflects on five decades of practice — and on the moment clinical inquiry became subordinate to ideology. Dr Stephen Levine's account of how WPATH abandoned scientific caution resonates sharply in Britain, where the Cass Review reached strikingly similar conclusions about the NHS's own gender services. His insistence that admitting uncertainty is a medical virtue, not a failure, speaks directly to the rebuilding now under way after the closure of the Tavistock.
Dr Stephen Levine has spent five decades at the centre of gender medicine in America. He co-directed one of the country's earliest gender identity clinics from 1974, chaired the committee that produced WPATH's fifth Standards of Care, and left the organisation in 2002 after concluding that advocacy had displaced science. In this conversation with the Beyond Gender hosts, he reflects on what the field got right, what it subsequently abandoned, and why the loss of clinical curiosity carries consequences that extend far beyond any single country. The transformation Levine describes will be painfully familiar to anyone who has followed events in Britain. He watched professional conferences turn from places of open inquiry into settings where dissent was met with booing rather than counterargument. The culture that silenced clinicians in American institutions did not stay in America. It shaped the training of British practitioners, the guidelines adopted by NHS gender services, and the atmosphere that made it so difficult for anyone inside the system to raise concerns about the speed and certainty with which young people were being placed on medical pathways. That context matters enormously when set against the Cass Review. Hilary Cass found that the evidence base for puberty blockers and cross-sex hormones in young people was remarkably thin, and that a climate of professional fear had prevented the kind of honest scrutiny that medicine depends on. Levine's account from the American side tells a parallel story. WPATH, the body whose standards NHS England once cited, evolved into something closer to an advocacy organisation, with peer review giving way to consensus-by-affirmation. Understanding that trajectory helps explain why a generation of clinicians across the English-speaking world found it professionally dangerous to say they did not know. Levine's insistence on sitting with uncertainty is one of the episode's most striking features. He argues that honest acknowledgement of what psychiatry does not understand is not a failure but a clinical and ethical obligation. The widely repeated claim of a two per cent regret rate, he suggests, does not survive serious scrutiny; nor does the confident assertion that gender dysphoria is simply an innate characteristic that medical intervention can straightforwardly resolve. These are precisely the claims that underpinned the Tavistock model and that the Cass Review found to be unsupported by robust evidence. For British listeners, the episode arrives at a moment of genuine reckoning. The Tavistock's Gender Identity Development Service has closed, NHS England has sharply restricted the prescription of puberty blockers to young people outside clinical trials, and new regional hubs are being built on the promise of a more cautious, psychotherapeutically grounded approach. Levine's reflection on what was lost when curiosity gave way to compliance offers a sobering reminder of how long the reconstruction of good clinical culture can take — and how vigilant everyone involved in that process will need to be.
